ELS-tíðindi - nóvember 2000
ELS-tíðindi - nóvember 2000
ELS-tíðindi - nóvember 2000
- TAGS
- www.els.is
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
11/<strong>2000</strong><br />
Aðgengilegar<br />
umsóknir<br />
Eftirtaldar einkaleyfisumsóknir<br />
eru öllum<br />
aðgengilegar hjá Einkaleyfastofu,<br />
í samræmi við<br />
2. og 4. mgr. 22. gr. laga nr.<br />
17/1991 um einkaleyfi, með<br />
síðari breytingum, að<br />
liðnum 18 mánaða<br />
leyndartíma talið frá<br />
umsóknar- eða<br />
forgangsréttardegi.<br />
(21) 5381<br />
(22) 22.2.<strong>2000</strong><br />
(41) 25.8.<strong>2000</strong><br />
(51) A61K<br />
(54) 4-fenyl-pyridin afleiður.<br />
(71) F. Hoffmann-La Roche AG, 124<br />
Grenzacherstrasse, CH-4070 Basel,<br />
Sviss.<br />
(72) Michael Bös, Montreal, Quebec,<br />
Kanada; Quirico Branca, Binningen,<br />
Sviss; Guido Galley, Rheinfelden,<br />
Þýskalandi; Thierry Godel, Basel,<br />
Sviss; Torsten Hoffmann, Birsfelden,<br />
Sviss; Walter Hunkeler, Magden,<br />
Sviss; Patrick Schnider, Oberwil,<br />
Sviss; Heinz Stadler, Rheinfelden,<br />
Sviss.<br />
(74) Örn Þór, hrl., Skúlagötu 63, 105<br />
Reykjavík.<br />
(30) 24.2.99, EP, 99103504.9<br />
29.11.99, EP, 99123689.4<br />
(21) 5465<br />
(22) 19.4.<strong>2000</strong><br />
(41) 19.4.<strong>2000</strong><br />
(51) C07D 231/56; A61K 31/415<br />
(54) Indazól bíóísóster umskipting á<br />
katekóli í meðferðalega virkum<br />
efnasamböndum.<br />
(71) Pfizer Products Inc., Eastern Point<br />
Road, Groton, Connecticut 06340,<br />
Bandaríkjunum.<br />
(72) Anthony Marfat, Mystic, Connecticut,<br />
Bandaríkjunum.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 4.11.97, US, 60/064,229<br />
4.11.97, US, 60/064,187<br />
4.11.97, US, 60/064,024<br />
4.11.97, US, 60/064,228<br />
4.11.97, US, 60/064,198<br />
(85) 19.4.<strong>2000</strong><br />
(86) 26.10.98, PCT/IB98/01710<br />
<strong>ELS</strong> <strong>tíðindi</strong> 75<br />
(21) 5504<br />
(22) 19.5.<strong>2000</strong><br />
(41) 19.5.<strong>2000</strong><br />
(51) A61K 31/00<br />
(54) Samsetning virk við meðhöndlun á<br />
getuleysi.<br />
(71) Pfizer Products Inc., Eastern Point<br />
Road, Groton, Connecticut 06340,<br />
Bandaríkjunum.<br />
(72) Michael Grant Wyllie, Canterbury,<br />
Kent, Bretlandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 16.12.97, US, 60/069,741<br />
(85) 19.5.<strong>2000</strong><br />
(86) 29.10.98, PCT/IB98/01723<br />
(21) 5513<br />
(22) 26.5.<strong>2000</strong><br />
(41) 26.5.<strong>2000</strong><br />
(51) C07D 471/04; C07D 401/06; C07D<br />
401/14; C07D 519/00; A61K 31/415;<br />
A61K 31/44<br />
(54) Intergrín viðtaka mótlyf.<br />
(71) Merck & Co., Inc., 126 East<br />
Lincoln Avenue, Rahway, New<br />
Jersey 07065, Bandaríkjunum.<br />
(72) Mark E. Duggan; Robert S.<br />
Meissner; John H. Hutchinson;<br />
Wasyl Halczenko; Ben C. Askew;<br />
Paul J. Coleman; Michael A. Patane;<br />
Jiabing Wang; Rahway, New Jersey,<br />
Bandaríkjunum.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 17.12.97, US, 60/069,910<br />
24.3.98, US, 60/079,197<br />
30.3.98, US, 60/079,944<br />
2.4.98, US, 60/080,397<br />
27.4.98, US, 60/083,251<br />
13.5.98, GB, 9810182.7<br />
20.5.98, GB, 9810882.2<br />
20.5.98, GB, 9810892.1<br />
26.5.98, GB, 9811283.2<br />
12.6.98, GB, 9812686.5<br />
13.7.98, US, 60/092,588<br />
13.7.98, US, 60/092,624<br />
11.9.98, US, 60/099,948<br />
13.10.98, GB, 9822331.6<br />
16.10.98, GB, 9822701.0<br />
(85) 26.5.<strong>2000</strong><br />
(86) 14.12.98, PCT/US98/26568<br />
(21) 5514<br />
(22) 26.5.<strong>2000</strong><br />
(41) 26.5.<strong>2000</strong><br />
(51) C07D 221/22; A61K 31/435; C07D<br />
471/08; C07D 498/08; C07D 513/08<br />
(54) Arýl sambrædd azapólýsýklísk<br />
efnasambönd.<br />
(71) Pfizer Products Inc., Eastern Point<br />
Road, Groton, Connecticut 06340,<br />
Bandaríkjunum.<br />
(72) Jotham Wadsworth Coe, Niantic;<br />
Paige Roanne Palmer Brooks,<br />
North Stonington; Connecticut,<br />
Bandaríkjunum.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 31.12.97, US, 60/070,245<br />
(85) 26.5.<strong>2000</strong><br />
(86) 13.11.98, PCT/IB98/01813<br />
(21) 5526<br />
(22) 9.6.<strong>2000</strong><br />
(41) 9.6.<strong>2000</strong><br />
(51) C07J 41/00; A61K 31/565; C07J 43/00;<br />
C07J 31/00; A61K 31/58<br />
(54) 11ß-Halógen-7alfa-setin estratríen,<br />
aðferð til framleiðslu á lyfjasamsetningum<br />
sem innihalda<br />
fyrrnefnd estratríen og notkun þeirra<br />
til framleiðslu á læknislyfjum.<br />
(71) Schering Aktiengesellschaft,<br />
Müllerstrasse 178, D-13353 Berlín,<br />
Þýskalandi.<br />
(72) Rolf Bohlmann; Nikolaus Heinrich;<br />
Helmut Hofmeister; Jorg Kroll;<br />
Hermann Künzer; Gerhard Sauer;<br />
Ludwig Zorn; Karl-Heinrich<br />
Fritzemeier; Monika Lessl;<br />
Rosemarie Lichtner; Yukishige<br />
Nishino; Karsten Parczyk; Martin<br />
Schneider; Berlín, Þýskalandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 23.12.97, DE, DE 19758390.3<br />
10.2.98, DE, DE 19806357.1<br />
(85) 9.6.<strong>2000</strong><br />
(86) 23.12.98, PCT/EP98/08470<br />
(21) 5538<br />
(22) 16.6.<strong>2000</strong><br />
(41) 16.6.<strong>2000</strong><br />
(51) C07C 249/02; C07C 251/20<br />
(54) Ný aðferð til framleiðslu á ketamíni.<br />
(71) Pfizer Products Inc., Eastern Point<br />
Road, Groton, Connecticut 06340,<br />
Bandaríkjunum.<br />
(72) Juan Carlos Colberg, Norwich; David<br />
Michael Pfisterer, Mystic; Geraldine<br />
Patricia Taber, Mystic; Connecticut,<br />
Bandaríkjunum.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 16.1.98, US, 60/071,600<br />
(85) 16.6.<strong>2000</strong><br />
(86) 15.10.98, PCT/IB98/01619<br />
(21) 5542<br />
(22) 20.6.<strong>2000</strong><br />
(41) 20.6.<strong>2000</strong><br />
(51) C07D 253/06; A61K 31/53<br />
(54) Tríazín efnasambönd til<br />
meðhöndlunar á truflunum í<br />
miðtaugakerfi (CNS).<br />
(71) Glaxo Group Limited, Glaxo<br />
Wellcome House, Berkeley Avenue,<br />
Greenford, Middlesex UB6 ONN,<br />
Bretlandi.<br />
(72) Brian Cox; Mark Patrick Healy;<br />
Malcolm Stuart Nobbs; Gita<br />
Punjabhai Shah; Stevenage,<br />
Hertfordshire, Bretlandi.<br />
(74) Faktor einkaleyfaskrifstofa, ehf.,<br />
Pósthólf 678, 121 Reykjavík.<br />
(30) 22.12.97, GB, 9726987.2<br />
(85) 20.6.<strong>2000</strong><br />
(86) 18.12.98, PCT/EP98/08273